Cargando…

Chemoimmunotherapy in the First-Line Treatment of Chronic Lymphocytic Leukaemia: Dead Yet, or Alive and Kicking?

SIMPLE SUMMARY: Chemoimmunotherapy has been the cornerstone of the first-line treatment for chronic lymphocytic leukaemia for almost a decade: FCR (fludarabine, cyclophosphamide, rituximab) or BR (bendamustine, rixutimab) regimens for fit patients and G-CLB (obinutuzumab, chlorambucil) being the mos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smolej, Lukáš, Vodárek, Pavel, Écsiová, Dominika, Šimkovič, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267736/ https://www.ncbi.nlm.nih.gov/pubmed/34201565 http://dx.doi.org/10.3390/cancers13133134

Ejemplares similares

A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first‐line therapy administration in patients with chronic lymphocytic leukemia
por: Vodárek, Pavel, et al.
Publicado: (2022)

Bioinformatics: alive and kicking
por: Stein, Lincoln D
Publicado: (2008)

Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia
por: Šimkovič, Martin, et al.
Publicado: (2015)

PB1921: IS CHEMOIMMUNOTHERAPY (CIT) HISTORY IN THE FIRST LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA?
por: Parbutt, Catherine, et al.
Publicado: (2023)

LS1 Report: alive and kicking!
por: Katarina Anthony
Publicado: (2014)

Dead or Alive?
por: Greenbaum, Carla J.
Publicado: (2012)

The “Dead Alive”
por: Nason, R. B.
Publicado: (1859)

The “Dead-Alive.”
por: Nason, Richard Bird
Publicado: (1859)

The Dead Alive
Publicado: (1868)

Practical approach to management of chronic lymphocytic leukemia
por: Smolej, Lukáš, et al.
Publicado: (2015)

Ultrastructural histochemistry in biomedical research: Alive and kicking
por: Malatesta, Manuela
Publicado: (2018)

COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group
por: Šimkovič, Martin, et al.
Publicado: (2023)

Wanted, an Anthrax vaccine: Dead or Alive?
por: Smith, Kendall A
Publicado: (2005)

Erythropoietin for stroke treatment: dead or alive?
por: Minnerup, Jens, et al.
Publicado: (2011)

Wanted Plasmodium falciparum, dead or alive
por: Sow, Fatimata, et al.
Publicado: (2015)

Are in‐person scientific conferences dead or alive?
por: Dua, Nick, et al.
Publicado: (2021)

Not dead yet
por: Carroll, Sean
Publicado: (2007)

Alive and kicking: suicide rates and major soccer events in Austria, Germany and Switzerland
por: Pichler, Eva-Maria, et al.
Publicado: (2023)

Do the ‘brain dead’ merely appear to be alive?
por: Nair-Collins, Michael, et al.
Publicado: (2017)

HDL Is Not Dead Yet
por: Lorkowski, Shuhui Wang, et al.
Publicado: (2022)

Dead or alive? The manipulation of neuronal ensembles and pathways by daunorubicin
por: Bashir, Zafar Iqbal, et al.
Publicado: (2017)

Dead or alive? Pitfall of survival analysis with TCGA datasets
por: Idogawa, Masashi, et al.
Publicado: (2021)

Axillary lymph node dissection: Dead or still alive?
por: Beck, Anna C., et al.
Publicado: (2023)

Enterococcus gallinarum as a component of the Autoinfectome: the gut-liver-autoimmune rheumatic disease axis is alive and kicking
por: Bogdanos, Dimitrios P., et al.
Publicado: (2018)

Real-world Clinical Outcomes of First-Line Ibrutinib or Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia by Risk Status
por: Huang, Qing, et al.
Publicado: (2022)

The quantum divide: why Schrödinger's cat is either dead or alive
por: Gerry, Christopher C, et al.
Publicado: (2013)

Hydronaphthol—With Suggestions for Its Use in the Treatment of the Dental Pulp, Alive or Dead
por: Stowell, Sidney S.
Publicado: (1898)

Wanted Dead or Alive: A Correlate of Protection Against Dengue Virus
por: Gil, Lázaro, et al.
Publicado: (2019)

The EphB6 Receptor: Kinase-Dead but Very Much Alive
por: Strozen, Timothy G., et al.
Publicado: (2021)

Primary Amine Functionalized Carbon Dots for Dead and Alive Bacterial Imaging
por: Liu, Yuting, et al.
Publicado: (2023)

Dead or alive: animal sampling during Ebola hemorrhagic fever outbreaks in humans
por: Olson, Sarah H., et al.
Publicado: (2012)

Dead or alive: sediment DNA archives as tools for tracking aquatic evolution and adaptation
por: Ellegaard, Marianne, et al.
Publicado: (2020)

Dead or Alive? A Review of Perinatal Factors That Determine Canine Neonatal Viability
por: Uchańska, Oliwia, et al.
Publicado: (2022)

Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies
por: Kralickova, P., et al.
Publicado: (2017)

Targeted treatment for chronic lymphocytic leukemia: clinical potential of obinutuzumab
por: Smolej, Lukáš
Publicado: (2014)

Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM)
por: González-Rincón, Julia, et al.
Publicado: (2021)

First-Line Treatment for Advanced SCLC: What Is Left Behind and Beyond Chemoimmunotherapy
por: Giunta, Emilio Francesco, et al.
Publicado: (2022)

Editorial Commentary: Dead or Alive: Can Viability Staining Predict Response to Tuberculosis Treatment?
por: Lawn, Stephen D., et al.
Publicado: (2015)

Treatment of Bing–Neel syndrome with first line sequential chemoimmunotherapy: A case report
por: Gavriatopoulou, Maria, et al.
Publicado: (2019)

Systemic therapy options following first-line chemoimmunotherapy in small-cell lung cancer
por: Pacheco, Jose M.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3itc4dnqts0hoajdgmajem1ai0